A new study led by a research team from Harvard Medical School and Mass. Eye and Ear, describes how bacteria adapted to the modern hospital environment and repeatedly cause antibiotic-resistant...

In a significant advance against drug-resistant superbugs, investigators supported by the Harvard-wide Program on Antibiotic Resistance have identified a new class of synthetic antibiotics that have...

Survival of mass extinctions helps to explain near indestructible properties of hospital "superbugs" 

Boston, Mass. — Leading hospital “superbugs,” known as the enterococci, arose from an...

In March 2017, Michael Gilmore, PhD, Director of the Harvard Infectious Disease Institute, chaired a blue ribbon panel that reviewed the most promising applications for the Antimicrobial Resistance...

Boston, Mass. —  Researchers at Massachusetts Eye and Ear have discovered a new mutation in a highly antibiotic-resistant strain of E. coli that resists clearance by the body’s own immune system by...

Findings described in Nature Communications

BOSTON, MASS. – Scientists from Massachusetts Eye and Ear/Harvard Medical School Department of Ophthalmology have used the power of new genomic technology...